Drugs / Emivirine
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 24 trials | ||||||
| Phase 2 | NCT00002413 | — | HIV infectious disease | Triangle Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT00002418 | — | HIV infectious disease | Bristol-Myers Squibb | Terminated | No outcome recorded |
| Phase 2 | NCT00002420 | — | HIV infectious disease | Bristol-Myers Squibb | Terminated | No outcome recorded |
| Phase 2 | NCT00002412 | — | HIV infectious disease | Triangle Pharmaceuticals | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00002215 | — | HIV infectious disease | Triangle Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Emivirine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002418 ↗ |
| Known as | Coactinon | ChEMBL registry synonym — accepted as the source's own label CHEMBL35033 ↗ |
| Known as | Emivirina | ChEMBL registry synonym — accepted as the source's own label CHEMBL35033 ↗ |
| Known as | MKC-442 | ChEMBL registry synonym — accepted as the source's own label CHEMBL35033 ↗ |
| Modality | Small molecule | — CHEMBL35033 ↗ |